Foreword "Advances in flood forecasting"

Foreword Foreword

foreword

0

Foreword Lane & Lip Advances in therapy for atrial fibrillation Foreword

Two epidemiological studies have demonstrated that the lifetime prevalence of atrial fibrillation (AF) among people aged 40 years or more is roughly one in four [1,2]. AF increases in prevalence with age, ranging from 0.5% in people aged 50–59 years to almost 9% in those aged 80 years or more, and is associated with a high risk of morbidity and mortality from heart failure, stroke and thromboem...

Editorial Foreword

Evidence is steadily accumulating that a large number of diseases in which historical therapies have made no signifi cant impact in outcome are suddenly for the fi rst time effectively treated to yield outcomes unimaginable with prior therapies. Because of the complexities of signaling mechanisms and variation in these mechanisms between disease processes, thorough and standardized testing of e...

Editorial Foreword

Welcome to the inaugural issue of Vascular Health and Risk Management. It is our hope that this journal will provide a vehicle for the timely publication of important clinical information from studies undertaken by the international scientific community in academia and other institutions (ie, public, private, and government). Here at Dove Medical Press, we recognize that it is going to take som...